AcelRx Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ACRX and buy or sell other stocks, ETFs, and their options commission-free!

About ACRX

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. 

CEO
Vincent J. Angotti, MBA
CEOVincent J. Angotti, MBA
Employees
13
Employees13
Headquarters
San Mateo, California
HeadquartersSan Mateo, California
Founded
2005
Founded2005
Employees
13
Employees13

ACRX Key Statistics

Market cap
14.70M
Market cap14.70M
Price-Earnings ratio
-0.97
Price-Earnings ratio-0.97
Dividend yield
—
Dividend yield—
Average volume
1.88M
Average volume1.88M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.19
52 Week high$1.19
52 Week low
$0.38
52 Week low$0.38

People also own

Based on the portfolios of people who own ACRX. This list is generated using Robinhood data, and it’s not a recommendation.
Zomedica
SNDL
NuCana
Tonix Pharmaceuticals
Ideanomics
Bionano Genomics
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.